MPI
MEDP icon

Mairs & Power Inc’s Medpace MEDP Stock Holding History

Mairs & Power Inc’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.9M Buy
86,715
+995
+1% +$459K 0.42% 47
2026
Q1 		$41.2M Buy
85,720
+19,055
+29% +$9.76M 0.42% 51
2025
Q4 		$37.4M Sell
66,665
-2,918
-4% -$1.66M 0.36% 50
2025
Q3 		$35.8M Sell
69,583
-6,603
-9% -$2.88M 0.34% 50
2025
Q2 		$23.9M Buy
76,186
+43,753
+135% +$13.1M 0.24% 58
2025
Q1 		$9.88M Buy
32,433
+25
+0.1% +$8.41K 0.1% 72
2024
Q4 		$10.8M Buy
32,408
+2,646
+9% +$897K 0.1% 72
2024
Q3 		$9.93M Buy
29,762
+953
+3% +$362K 0.09% 74
2024
Q2 		$11.9M Buy
28,809
+20
+0.1% +$7.92K 0.11% 64
2024
Q1 		$11.6M Sell
28,789
-2,400
-8% -$844K 0.11% 68
2023
Q4 		$9.56M Sell
31,189
-5,902
-16% -$1.59M 0.1% 74
2023
Q3 		$8.98M Buy
37,091
+6
+0% +$1.53K 0.11% 73
2023
Q2 		$8.91M Buy
37,085
+1,635
+5% +$340K 0.1% 73
2023
Q1 		$6.67M Buy
35,450
+3,995
+13% +$826K 0.08% 85
2022
Q4 		$6.68M Hold
31,455
– – 0.08% 85
2022
Q3 		$4.94M Buy
+31,455
New +$5.02M 0.06% 94

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Mairs & Power Inc's MEDP Position: Q2 2026 in Review

Mairs & Power Inc increased its Medpace (MEDP) stake by 1.2% in Q2 2026, buying an estimated $459K and bringing the position to 86,715 shares worth $45.9M. The position accounts for 0.42% of the portfolio, ranked #47.

Mairs & Power Inc first reported a position in MEDP in Q3 2022 and has held it in 16 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Mairs & Power Inc held 86,715 shares of Medpace worth $45.9M as of Q2 2026.
  • Mairs & Power Inc bought 995 Medpace shares in Q2 2026, an estimated $459K.
  • Medpace made up 0.42% of Mairs & Power Inc's portfolio in Q2 2026, its #47 holding.
  • Mairs & Power Inc first reported a position in Medpace in Q3 2022 and has held it in 16 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Mairs & Power Inc's 13F filing for Q2 2026, filed 14 Aug 2026.